VBI Vaccines, Inc.
(Toronto Stock Exchange : VBIV)

( )
VBIV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen Inc.
CELGCelgene Corporation
GILDGilead Sciences, Inc.
BIIBBiogen Inc.
REGNRegeneron Pharmaceuticals, Inc.
NKTRNektar Therapeutics
VRTXVertex Pharmaceuticals Incorporated
ALXNAlexion Pharmaceuticals, Inc.
ILMNIllumina, Inc.
AAgilent Technologies, Inc.
EXASExact Sciences Corporation
INCYIncyte Corporation
BLUEBluebird Bio, Inc.
SRPTSarepta Therapeutics, Inc.
BMRNBioMarin Pharmaceutical Inc.

Company Profile

VBI Vaccines, Inc. is a biopharmaceutical company, which develops next generation vaccines to address unmet needs in infectious disease and immuno-oncology. Its products portfolio includes Sci-B-Vac, HBV, CMV Vaccine, GBM Immunotherapy and RSV Vaccine. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.